New Antibody Formulations Allow Antibodies To Target Structures Hidden Within Cells

A new lipid nanoparticle platform delivers full-length antibodies inside cells, unlocking intracellular targets in cancer, autoimmune disease, and Parkinson’s.

Raccontata daforbes.com